N-Pyridin-3-yl- and N-quinolin-3-yl-benzamides: Modulators of Human Vanilloid Receptor 1 (TRPV1)
摘要:
High throughput screening of our compound library revealed a series of N-pyridyl-3-benzamides as low micromolar agonists of the human TRPV1 receptor. Synthesis of analogs in this series led to the discovery of a series of N-quinolin-3-yl-benzamides as low nanomolar antagonists of human TRPV1. (C) 2008 Elsevier Ltd. All rights reserved.
compounds showed broad‐spectrum antimycobacterial activity against M. tuberculosis H37Ra, M. smegmatis and M. aurum. N‐(pyridin‐2‐yl)benzamides were generally more active than N‐(pyridin‐3‐yl)benzamides, indicating that N‐1 in the parental structure of N‐pyrazinylbenzamides might be more important for antimycobacterial activity than N‐4. Marginal antibacterial and antifungal activity was observed for title
N-Pyridin-3-yl- and N-quinolin-3-yl-benzamides: Modulators of Human Vanilloid Receptor 1 (TRPV1)
作者:Michele C. Jetter、James J. McNally、Mark A. Youngman、Mark E. McDonnell、Adrienne E. Dubin、Nadia Nasser、Sui-Po Zhang、Ellen E. Codd、Ray W. Colburn、Dennis R. Stone、Michael R. Brandt、Christopher M. Flores、Scott L. Dax
DOI:10.1016/j.bmcl.2008.02.075
日期:2008.4
High throughput screening of our compound library revealed a series of N-pyridyl-3-benzamides as low micromolar agonists of the human TRPV1 receptor. Synthesis of analogs in this series led to the discovery of a series of N-quinolin-3-yl-benzamides as low nanomolar antagonists of human TRPV1. (C) 2008 Elsevier Ltd. All rights reserved.